ARWR logo

ARWR Retained earnings

annual retained earnings:

-$1.63B-$599.49M(-58.43%)
September 30, 2024

Summary

  • As of today (May 29, 2025), ARWR annual retained earnings is -$1.63 billion, with the most recent change of -$599.49 million (-58.43%) on September 30, 2024.
  • During the last 3 years, ARWR annual retained earnings has fallen by -$980.83 million (-152.14%).
  • ARWR annual retained earnings is now -1707382.14% below its all-time high of -$95.20 thousand, reached on September 30, 2003.

Performance

ARWR Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRbalance sheet metrics

quarterly retained earnings:

-$1.43B+$370.44M(+20.60%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ARWR quarterly retained earnings is -$1.43 billion, with the most recent change of +$370.44 million (+20.60%) on March 31, 2025.
  • Over the past year, ARWR quarterly retained earnings has dropped by -$143.97 million (-11.21%).
  • ARWR quarterly retained earnings is now -1500071.22% below its all-time high of -$95.20 thousand, reached on September 30, 2003.

Performance

ARWR quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ARWR Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-58.4%-11.2%
3 y3 years-152.1%-115.3%
5 y5 years-287.7%-223.3%

ARWR Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-152.1%at low-115.3%+20.6%
5 y5-year-287.7%at low-223.3%+20.6%
alltimeall time<-9999.0%at low<-9999.0%+20.6%

ARWR Retained earnings History

DateAnnualQuarterly
Mar 2025
-
-$1.43B(-20.6%)
Dec 2024
-
-$1.80B(+10.6%)
Sep 2024
-$1.63B(+58.4%)
-$1.63B(+11.7%)
Jun 2024
-
-$1.45B(+13.3%)
Mar 2024
-
-$1.28B(+10.8%)
Dec 2023
-
-$1.16B(+12.9%)
Sep 2023
-$1.03B(+25.0%)
-$1.03B(+12.0%)
Jun 2023
-
-$916.35M(+12.7%)
Mar 2023
-
-$813.40M(-5.6%)
Dec 2022
-
-$862.08M(+5.0%)
Sep 2022
-$820.75M(+27.3%)
-$820.75M(+11.6%)
Jun 2022
-
-$735.24M(+10.9%)
Mar 2022
-
-$663.20M(-6.3%)
Dec 2021
-
-$707.56M(+9.8%)
Sep 2021
-$644.69M(+28.0%)
-$644.69M(+10.9%)
Jun 2021
-
-$581.32M(+5.4%)
Mar 2021
-
-$551.39M(+5.1%)
Dec 2020
-
-$524.58M(+4.1%)
Sep 2020
-$503.84M(+20.2%)
-$503.84M(+10.6%)
Jun 2020
-
-$455.41M(+3.1%)
Mar 2020
-
-$441.80M(+4.7%)
Dec 2019
-
-$421.96M(+0.6%)
Sep 2019
-$419.29M(-14.0%)
-$419.29M(-2.7%)
Jun 2019
-
-$431.00M(-4.5%)
Mar 2019
-
-$451.33M(-5.0%)
Dec 2018
-
-$475.23M(-2.5%)
Sep 2018
-$487.27M(+12.6%)
-$487.27M(+2.3%)
Jun 2018
-
-$476.50M(+3.4%)
Mar 2018
-
-$460.90M(+3.3%)
Dec 2017
-
-$446.01M(+3.0%)
Sep 2017
-$432.82M(+8.6%)
-$432.82M(+2.5%)
Jun 2017
-
-$422.08M(+1.3%)
Mar 2017
-
-$416.56M(+1.5%)
Dec 2016
-
-$410.52M(+3.0%)
Sep 2016
-$398.44M(+25.8%)
-$398.44M(+5.9%)
Jun 2016
-
-$376.21M(+5.4%)
Mar 2016
-
-$356.79M(+6.2%)
Dec 2015
-
-$335.98M(+6.1%)
Sep 2015
-$316.71M(+40.9%)
-$316.71M(+8.5%)
Jun 2015
-
-$291.97M(+5.8%)
Mar 2015
-
-$276.03M(+11.6%)
Dec 2014
-
-$247.35M(+10.0%)
Sep 2014
-$224.77M(+35.3%)
-$224.77M(+11.1%)
Jun 2014
-
-$202.34M(+6.1%)
Mar 2014
-
-$190.71M(+7.9%)
Dec 2013
-
-$176.77M(+6.4%)
Sep 2013
-$166.14M(+23.1%)
-$166.14M(+9.0%)
Jun 2013
-
-$152.45M(+4.2%)
Mar 2013
-
-$146.37M(+4.8%)
Dec 2012
-
-$139.61M(+3.4%)
Sep 2012
-$135.00M
-$135.00M(+4.1%)
Jun 2012
-
-$129.68M(+6.6%)
DateAnnualQuarterly
Mar 2012
-
-$121.69M(+4.6%)
Dec 2011
-
-$116.36M(+2.2%)
Sep 2011
-$113.87M(+2.8%)
-$113.87M(+2.5%)
Jun 2011
-
-$111.10M(+1.7%)
Mar 2011
-
-$109.28M(-2.6%)
Dec 2010
-
-$112.18M(+1.3%)
Sep 2010
-$110.74M(+5.5%)
-$110.74M(+1.8%)
Jun 2010
-
-$108.74M(+0.3%)
Mar 2010
-
-$108.37M(+1.7%)
Dec 2009
-
-$106.51M(+1.5%)
Sep 2009
-$104.97M(+22.8%)
-$104.97M(+3.6%)
Jun 2009
-
-$101.34M(+2.6%)
Mar 2009
-
-$98.82M(+5.7%)
Dec 2008
-
-$93.53M(+9.4%)
Sep 2008
-$85.50M(+46.4%)
-$85.50M(+11.3%)
Jun 2008
-
-$76.84M(+10.8%)
Mar 2008
-
-$69.34M(+8.9%)
Dec 2007
-
-$63.64M(+9.0%)
Sep 2007
-$58.41M(+105.1%)
-$58.41M(+14.9%)
Jun 2007
-
-$50.83M(+32.5%)
Mar 2007
-
-$38.36M(+19.2%)
Dec 2006
-
-$32.18M(+13.0%)
Sep 2006
-$28.48M(+200.4%)
-$28.48M(+44.6%)
Jun 2006
-
-$19.70M(+25.3%)
Mar 2006
-
-$15.72M(+24.6%)
Dec 2005
-
-$12.62M(+33.1%)
Sep 2005
-$9.48M(+265.7%)
-$9.48M(+45.3%)
Jun 2005
-
-$6.52M(+87.1%)
Mar 2005
-
-$3.49M(-15.6%)
Dec 2004
-
-$4.13M(+59.3%)
Sep 2004
-$2.59M(+2622.9%)
-$2.59M(+132.4%)
Jun 2004
-
-$1.12M(+133.7%)
Mar 2004
-
-$477.10K(+58.4%)
Dec 2003
-
-$301.20K(+216.4%)
Sep 2003
-$95.20K(-99.0%)
-$95.20K(-99.0%)
Jun 2003
-
-$9.82M(+0.5%)
Mar 2003
-
-$9.76M(+1.1%)
Dec 2002
-
-$9.66M(+0.5%)
Sep 2002
-$9.61M(+2.6%)
-$9.61M(+0.9%)
Jun 2002
-
-$9.53M(+0.9%)
Mar 2002
-
-$9.44M(+0.1%)
Dec 2001
-
-$9.43M(+0.7%)
Sep 2001
-$9.37M(+2.0%)
-$9.37M(+0.7%)
Jun 2001
-
-$9.31M(+0.4%)
Mar 2001
-
-$9.27M(+0.6%)
Dec 2000
-
-$9.22M(+0.4%)
Sep 2000
-$9.18M(+1.5%)
-$9.18M(-0.4%)
Jun 2000
-
-$9.22M(+0.6%)
Mar 2000
-
-$9.16M(+0.6%)
Dec 1999
-
-$9.10M
Sep 1999
-$9.04M(-6.2%)
-
Sep 1998
-$9.64M(+2.4%)
-
Sep 1997
-$9.41M
-

FAQ

  • What is Arrowhead Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?

What is Arrowhead Pharmaceuticals annual retained earnings?

The current annual retained earnings of ARWR is -$1.63B

What is the all time high annual retained earnings for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual retained earnings is -$95.20K

What is Arrowhead Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, ARWR annual retained earnings has changed by -$599.49M (-58.43%)

What is Arrowhead Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of ARWR is -$1.43B

What is the all time high quarterly retained earnings for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly retained earnings is -$95.20K

What is Arrowhead Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, ARWR quarterly retained earnings has changed by -$143.97M (-11.21%)
On this page